An outbreak of serotype 19A pneumococcal pneumonia in a relief facility in Japan

Kei Nagano1, Satoshi Kawasaki2, Hiroshi Moro1

  • 1Department of Respiratory Medicine and Infectious Diseases, Niigata Graduate School of Medical and Dental Sciences, Chuo-ku, Niigata, Japan.

Insights

An outbreak of 19A Streptococcus pneumoniae occurred in a relief facility, causing pneumonia in 5.1% of residents. Further testing revealed the bacteria in 6.4% of non-ill residents, with 19A being the dominant serotype.

Area of Science:

  • Microbiology
  • Epidemiology
  • Infectious Diseases

Background:

  • Serotype 19A Streptococcus pneumoniae is a significant cause of invasive pneumococcal disease.
  • Outbreaks in congregate settings like relief facilities pose public health challenges.

Purpose of the Study:

  • To investigate an outbreak of 19A Streptococcus pneumoniae in a relief facility.
  • To determine the attack rate and identify the causative serotype.

Main Methods:

  • Retrospective analysis of clinical data from residents of a relief facility.
  • Collection and microbiological analysis of pharyngeal specimens from non-onset residents.

Main Results:

  • An outbreak of 19A Streptococcus pneumoniae was identified.
  • Pneumonia affected 5 out of 99 residents (5.1% attack rate).
  • Streptococcus pneumoniae was isolated from 6.4% of non-onset residents, with 5 cases identified as serotype 19A.

Conclusions:

  • Serotype 19A Streptococcus pneumoniae was the likely cause of the outbreak.
  • The findings highlight the potential for rapid transmission in communal living environments.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
427
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.8K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.2K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
246
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
524
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
706